The matters set forth herein have not been approved by any securities regulatory authority, nor has any securities regulatory authority passed upon the fairness or merits of the. | May 15, 2023
This quarterly newsletter provides essential updates on litigation, regulatory, legislative, and other notable developments involving chemicals of concern to business.